APOE and Alzheimer disease: APOE4 carriers, particularly homozygous individuals, are at substantially higher risk for AD, with emerging evidence suggesting that APOE4 homozygosity may represent a distinct autosomal recessive form of the disease (Fortea et al., 2024).